Holen Sie sich die Stockscreener-App
24.76
2.17%
-0.55
Vorhandelsmarkt:
24.73
-0.03
-0.12%
Schlusskurs vom Vortag:
$25.31
Offen:
$25.15
24-Stunden-Volumen:
2.09M
Relative Volume:
1.02
Marktkapitalisierung:
$2.97B
Einnahmen:
$59.61M
Nettoeinkommen (Verlust:
$-262.14M
KGV:
-6.3163
EPS:
-3.92
Netto-Cashflow:
$-247.49M
1W Leistung:
+26.07%
1M Leistung:
+24.30%
6M Leistung:
+62.47%
1J Leistung:
+185.58%
1-Tages-Spanne:
$24.22
$25.43
1-Wochen-Bereich:
$22.00
$27.08
52-Wochen-Spanne:
$8.29
$27.08
Arcutis Biotherapeutics Inc Stock (ARQT) Company Profile
Firmenname
Arcutis Biotherapeutics Inc
Sektor
Branche
Telefon
805-418-5006
Adresse
3027 TOWNSGATE ROAD, WESTLAKE VILLAGE, CA
Vergleichen Sie ARQT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARQT
Arcutis Biotherapeutics Inc
|
24.76 | 3.10B | 59.61M | -262.14M | -247.49M | -3.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Arcutis Biotherapeutics Inc Stock (ARQT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-25 | Eingeleitet | Goldman | Neutral |
| 2024-12-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-08-28 | Eingeleitet | Jefferies | Buy |
| 2024-01-03 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-10-26 | Herabstufung | Mizuho | Buy → Neutral |
| 2023-10-13 | Herabstufung | Goldman | Buy → Neutral |
| 2022-09-07 | Eingeleitet | Needham | Buy |
| 2022-03-17 | Eingeleitet | Goldman | Buy |
| 2021-06-30 | Eingeleitet | Mizuho | Buy |
| 2021-05-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-09 | Hochstufung | Goldman | Neutral → Buy |
| 2020-10-08 | Eingeleitet | Truist | Buy |
| 2020-02-25 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-02-25 | Eingeleitet | Cowen | Outperform |
| 2020-02-25 | Eingeleitet | Goldman | Neutral |
| 2020-02-25 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Arcutis Biotherapeutics Inc Aktie (ARQT) Neueste Nachrichten
Corton Capital Inc. Acquires New Position in Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
Historical volatility pattern of Arcutis Biotherapeutics Inc. visualizedQuarterly Growth Report & AI Forecast Swing Trade Picks - newser.com
What moving averages say about Arcutis Biotherapeutics Inc.July 2025 Retail & Free Reliable Trade Execution Plans - newser.com
Multi asset correlation models including Arcutis Biotherapeutics Inc.Market Trend Report & Weekly Top Stock Performers List - newser.com
How Arcutis Biotherapeutics Inc. stock reacts to Fed rate cutsJuly 2025 Highlights & Free Long-Term Investment Growth Plans - newser.com
Arcutis Biotherapeutics joins leaders at dermatology conference - Traders Union
Is Arcutis Biotherapeutics Inc. stock undervalued vs historical averages2025 Market Overview & Weekly High Potential Stock Alerts - newser.com
Will earnings trigger a reversal in Arcutis Biotherapeutics Inc.Trade Exit Summary & AI Forecast for Swing Trade Picks - newser.com
Combining price and volume data for Arcutis Biotherapeutics Inc.Share Buyback & Verified Entry Point Detection - newser.com
How Arcutis Biotherapeutics Inc. stock reacts to inflationary pressuresJuly 2025 Trends & Community Consensus Trade Alerts - newser.com
Advanced analytics toolkit walkthrough for Arcutis Biotherapeutics Inc.July 2025 Chart Watch & Free Technical Pattern Based Buy Signals - newser.com
Is Arcutis Biotherapeutics Inc. a candidate for recovery play2025 Market Trends & Accurate Buy Signal Alerts - newser.com
How high can Arcutis Biotherapeutics Inc. stock go2025 Trading Volume Trends & AI Driven Stock Price Forecasts - newser.com
Will Arcutis Biotherapeutics Inc. stock deliver consistent dividendsGold Moves & AI Driven Stock Movement Reports - newser.com
Will a bounce in Arcutis Biotherapeutics Inc. offer an exitQuarterly Performance Summary & Verified Chart Pattern Trade Signals - newser.com
What’s the recovery path for long term holders of Arcutis Biotherapeutics Inc.Market Performance Recap & Expert Verified Movement Alerts - newser.com
Leading vs lagging indicators on Arcutis Biotherapeutics Inc. performanceEarnings Overview Report & Safe Entry Point Identification - newser.com
Is Arcutis Biotherapeutics Inc. stock safe for conservative investorsShort Setup & Fast Gain Stock Trading Tips - newser.com
Arcutis Biotherapeutics Achieves 186.45% Return, Establishing It as a Multibagger in Biotechnology - Markets Mojo
Why hedge funds are buying Arcutis Biotherapeutics Inc. stockJuly 2025 Market Mood & AI Forecasted Entry/Exit Points - newser.com
Arcutis Biotherapeutics (NASDAQ:ARQT) Raised to Strong-Buy at Wall Street Zen - MarketBeat
Has Arcutis Biotherapeutics Inc. found a price floorJuly 2025 Breakouts & Detailed Earnings Play Strategies - newser.com
Is Arcutis Biotherapeutics Inc. stock dividend yield sustainableIPO Watch & Free Weekly Chart Analysis and Trade Guides - newser.com
How Arcutis Biotherapeutics Inc. stock reacts to global recession fearsTrend Reversal & Weekly Setup with High ROI Potential - newser.com
HC Wainwright Has Positive Forecast for ARQT FY2025 Earnings - MarketBeat
Arcutis Biotherapeutics (NASDAQ:ARQT) Upgraded by Zacks Research to Strong-Buy Rating - MarketBeat
Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells 40,000 Shares - MarketBeat
Why Arcutis Biotherapeutics (ARQT) Is Up 23.9% After Expanding ZORYVE to Pediatric Atopic Dermatitis - Yahoo Finance
HC Wainwright Has Positive Outlook for ARQT Q4 Earnings - MarketBeat
Arcutis Biotherapeutics, Inc. (ARQT) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Results: Arcutis Biotherapeutics, Inc. Confounded Analyst Expectations With A Surprise Profit - simplywall.st
What the charts say about Arcutis Biotherapeutics Inc. todayChart Signals & Reliable Price Action Trade Plans - newser.com
Is Arcutis Biotherapeutics Inc. stock poised for growthJuly 2025 Short Interest & AI Enhanced Trade Execution Alerts - newser.com
Volatility clustering patterns for Arcutis Biotherapeutics Inc.Trade Exit Report & Advanced Swing Trade Entry Plans - newser.com
Finanzdaten der Arcutis Biotherapeutics Inc-Aktie (ARQT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):